TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H100. A total of 39 filers reported holding TRACON PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 683 Capital Management, LLC | 995,000 | $3,134,000 | 0.33% |
| NEA Management Company, LLC | 2,759,217 | $8,692,000 | 0.30% |
| Eventide Asset Management | 900,000 | $2,835,000 | 0.16% |
| QVT Financial LP | 308,227 | $916,000 | 0.03% |
| Candriam S.C.A. | 143,000 | $450,000 | 0.01% |
| Virtu Financial LLC | 23,684 | $75,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 13,352 | $42,000 | 0.00% |
| BLUESTEIN R H & CO LLC | 16,000 | $50,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 54,135 | $171,000 | 0.00% |
| Alyeska Investment Group, L.P. | 97,676 | $308,000 | 0.00% |